Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy.

Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, Fox AN, Dove LM, Brown RS.

Liver Int. 2014 Jun 6. doi: 10.1111/liv.12616. [Epub ahead of print]

PMID:
24905624
[PubMed - as supplied by publisher]
2.

Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.

Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P; HIVTR Investigators.

Am J Transplant. 2014 May;14(5):1129-35. doi: 10.1111/ajt.12668. Epub 2014 Mar 17.

PMID:
24636466
[PubMed - in process]
3.

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.

Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.

Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9.

PMID:
23583433
[PubMed - indexed for MEDLINE]
Free Article
4.

Smoking and hepatocellular carcinoma mortality.

Siegel AB, Conner K, Wang S, Jacobson JS, Hershman DL, Hidalgo R, Verna EC, Halazun K, Brubaker W, Zaretsky J, Moniodis A, Delgado-Cruzata L, Dove L, Emond J, Kato T, Brown RS Jr, Neugut AI.

Exp Ther Med. 2012 Jan;3(1):124-128. Epub 2011 Sep 19.

PMID:
22969856
[PubMed]
Free PMC Article
5.

Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.

Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, Jacobson JS, Hershman DL, Verna EC, Zaretsky J, Halazun K, Dove L, Brown RS Jr, Neugut AI, Kato T, Remotti H, Coppleson YJ, Emond JC.

Transplantation. 2012 Sep 15;94(5):539-43.

PMID:
22864187
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2012 Jun;18(6):716-26. doi: 10.1002/lt.23411.

PMID:
22328294
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, Jacobson IM.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261-8. doi: 10.1097/QAI.0b013e3182324af9.

PMID:
21876446
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Obesity and microvascular invasion in hepatocellular carcinoma.

Siegel AB, Wang S, Jacobson JS, Hershman DL, Lim EA, Yu J, Ferrante L, Devaraj KM, Remotti H, Scrudato S, Halazun K, Emond J, Dove L, Brown RS Jr, Neugut AI.

Cancer Invest. 2010 Dec;28(10):1063-9. doi: 10.3109/07357907.2010.483500.

PMID:
21077757
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Coffin CS, Stock PG, Dove LM, Berg CL, Nissen NN, Curry MP, Ragni M, Regenstein FG, Sherman KE, Roland ME, Terrault NA.

Am J Transplant. 2010 May;10(5):1268-75. doi: 10.1111/j.1600-6143.2010.03070.x. Epub 2010 Mar 19.

PMID:
20346065
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Florman S, Blumberg E, Stosor V, Jayaweera DT, Huprikar S, Fung J, Pruett T, Stock P, Ragni M.

Gastroenterology. 2010 Jan;138(1):159-64. doi: 10.1053/j.gastro.2009.09.053. Epub 2009 Sep 30.

PMID:
19800334
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.

Evon DM, Ramcharran D, Belle SH, Terrault NA, Fontana RJ, Fried MW; Virahep-C Study Group.

Am J Gastroenterol. 2009 Dec;104(12):2949-58. doi: 10.1038/ajg.2009.528. Epub 2009 Sep 29.

PMID:
19789525
[PubMed - indexed for MEDLINE]
12.

Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.

Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH; Virahep-C Study Group.

Gastroenterology. 2009 Sep;137(3):873-84, 884.e1. doi: 10.1053/j.gastro.2009.05.060. Epub 2009 Jun 13.

PMID:
19527724
[PubMed - indexed for MEDLINE]
13.

Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.

Iuliano AD, Feingold E, Wahed AS, Kleiner DE, Belle SH, Conjeevaram HS, Zmuda J, Liang TJ, Yee LJ; Virahep-C Study.

Intervirology. 2009;52(1):49-56. doi: 10.1159/000214380. Epub 2009 Apr 25.

PMID:
19401628
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.

Yee LJ, Im K, Borg B, Yang H, Liang TJ; Virahep-C Study.

Genes Immun. 2009 Jun;10(4):365-72. doi: 10.1038/gene.2009.26. Epub 2009 Apr 23.

PMID:
19387461
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.

Hoofnagle JH, Wahed AS, Brown RS Jr, Howell CD, Belle SH; Virahep-C Study Group.

J Infect Dis. 2009 Apr 15;199(8):1112-20. doi: 10.1086/597384.

PMID:
19284286
[PubMed - indexed for MEDLINE]
Free Article
16.

Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH; VIRAHEP-C Study Group.

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1403-11. doi: 10.1016/j.cgh.2008.08.006. Epub 2008 Aug 19.

PMID:
19081528
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.

Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H; Virahep-C Study.

Antimicrob Agents Chemother. 2009 Feb;53(2):615-21. doi: 10.1128/AAC.00947-08. Epub 2008 Oct 13.

PMID:
18852273
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.

Burton JR Jr, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR; Virahep-C Study Group.

J Hepatol. 2008 Sep;49(3):329-38. doi: 10.1016/j.jhep.2008.05.020. Epub 2008 Jun 23.

PMID:
18644644
[PubMed - indexed for MEDLINE]
19.

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, Howell C, Ramcharran D, Rosen HR, Taylor MW, Liang TJ, Yang H; Virahep-C Study Group.

J Hepatol. 2008 Aug;49(2):184-91. doi: 10.1016/j.jhep.2008.04.011. Epub 2008 May 20.

PMID:
18571276
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cultural kitchens: changing the power balance.

Dove L, Friedrick T, Cuming C.

Can Nurse. 2008 Feb;104(2):9-10. No abstract available.

PMID:
18320893
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk